-
1دورية أكاديمية
المؤلفون: Shibo Huang, Yanping Huang, Chunyan Li, Yiwen Liang, Miaoyan Huang, Raoshan Luo, Weiming Liang
المصدر: Frontiers in Immunology, Vol 14 (2024)
مصطلحات موضوعية: PD-1 inhibitor, programmed cell death protein 1 inhibitor, programmed death-ligand 1 inhibitor, muscle invasive bladder cancer, neoadjuvant, complication, Immunologic diseases. Allergy, RC581-607
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Tomoaki Sonoda, Yukihiro Umeda, Yoshiki Demura, Toshihiko Tada, Koki Nakashima, Masaki Anzai, Makiko Yamaguchi, Akikazu Shimada, Masahiro Ohi, Chisato Honjo, Yuko Waseda, Masaya Akai, Tamotsu Ishizuka
المصدر: Cancer Medicine, Vol 12, Iss 12, Pp 13041-13053 (2023)
مصطلحات موضوعية: immune checkpoint inhibitor, nab‐paclitaxel, non‐small cell lung cancer, programmed cell death 1 inhibitor, programmed death ligand 1 inhibitor, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2045-7634
-
3دورية أكاديمية
المؤلفون: Zeng, TianniAff1, Aff3, Fang, Xiaojie, Lu, Jinhua, Zhong, Yazhen, Lin, Xianlei, Lin, Zechen, Wang, Nan, Jiang, Jing, Lin, ShengyouAff1, IDs0038402104028z_cor9
المصدر: International Journal of Colorectal Disease: Clinical and Molecular Gastroenterology and Surgery. 37(1):251-258
-
4دورية أكاديمية
المؤلفون: Shukui Qin, Zhenggang Ren, Yin-Hsun Feng, Thomas Yau, Baocheng Wang, Haitao Zhao, Yuxian Bai, Shanzhi Gu, Lindong Li, Sairy Hernandez, Derek-Zhen Xu, Sohail Mulla, Yifan Wang, Hui Shao, Ann Lii Cheng
المصدر: Liver Cancer, Pp 1-13 (2021)
مصطلحات موضوعية: checkpoint inhibitor, immunotherapy, liver cancer, systemic treatment, chinese patients, overall survival, programmed death-ligand 1 inhibitor, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
5دورية أكاديمية
المؤلفون: Yoshitaka Yamaguchi, Hikaru Nagasawa, Yuji Katagiri, Manabu Wada
المصدر: Journal of Medical Case Reports, Vol 14, Iss 1, Pp 1-4 (2020)
مصطلحات موضوعية: Atezolizumab, Encephalitis, Immune checkpoint inhibitor, Immune-related adverse event, Lung adenocarcinoma, Programmed death ligand 1 inhibitor, Medicine
وصف الملف: electronic resource
-
6دورية أكاديمية
المؤلفون: Yamaguchi, YoshitakaAff1, Nagasawa, Hikaru, Katagiri, Yuji, Wada, Manabu
المصدر: Journal of Medical Case Reports. 14(1)
-
7دورية أكاديمية
المؤلفون: Jong-Mu Sun
المصدر: Precision and Future Medicine, Vol 1, Iss 1, Pp 3-9 (2017)
مصطلحات موضوعية: Carcinoma, non-small-cell lung, First-line therapy, Programmed death 1 inhibitor, Programmed death ligand 1 expression, Programmed death ligand 1 inhibitor, Medicine
وصف الملف: electronic resource
-
8دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
9دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
10
المؤلفون: Jing Jiang, Yazhen Zhong, Xiaojie Fang, Shengyou Lin, Xianlei Lin, Zechen Lin, Tianni Zeng, Nan Wang, Jinhua Lu
المصدر: International Journal of Colorectal Disease
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Efficacy, Colorectal cancer, medicine.medical_treatment, Cochrane Library, Programmed death ligand 1 inhibitor, Immune checkpoint inhibitors, Internal medicine, Medicine, Humans, Programmed cell death protein 1 inhibitor, Adverse effect, business.industry, Gastroenterology, Odds ratio, Immunotherapy, Hepatology, medicine.disease, Progression-Free Survival, Clinical trial, Meta-analysis, Original Article, Safety, business, Colorectal Neoplasms